UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Xencor Inc (XNCR)

Xencor Inc (XNCR)
10.81 x 9 10.83 x 5
Post-market by (Cboe BZX)
10.84 -0.03 (-0.28%) 04/24/25 [NASDAQ]
10.81 x 9 10.83 x 5
Post-market 10.84 unch (unch) 16:02 ET
Quote Overview for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
10.40
Day High
10.94
Open 10.82
Previous Close 10.87 10.87
Volume 618,486 618,486
Avg Vol 1,009,049 1,009,049
Stochastic %K 77.20% 77.20%
Weighted Alpha -57.33 -57.33
5-Day Change +1.32 (+13.87%) +1.32 (+13.87%)
52-Week Range 7.16 - 27.24 7.16 - 27.24
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 765,922
  • Shares Outstanding, K 70,462
  • Annual Sales, $ 110,490 K
  • Annual Income, $ -232,620 K
  • EBIT $ -178 M
  • EBITDA $ -180 M
  • 60-Month Beta 0.90
  • Price/Sales 6.79
  • Price/Cash Flow N/A
  • Price/Book 1.11

Options Overview Details

View History
  • Implied Volatility 166.67% ( +14.36%)
  • Historical Volatility 91.80%
  • IV Percentile 93%
  • IV Rank 73.59%
  • IV High 216.55% on 04/10/25
  • IV Low 27.72% on 08/06/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 141
  • Open Int (30-Day) 129

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.63
  • Number of Estimates 7
  • High Estimate -0.20
  • Low Estimate -0.84
  • Prior Year -1.11
  • Growth Rate Est. (year over year) +43.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.16 +51.40%
on 04/09/25
Period Open: 12.95
13.17 -17.69%
on 03/25/25
-2.11 (-16.29%)
since 03/24/25
3-Month
7.16 +51.40%
on 04/09/25
Period Open: 19.65
20.08 -46.03%
on 01/27/25
-8.81 (-44.83%)
since 01/24/25
52-Week
7.16 +51.40%
on 04/09/25
Period Open: 19.02
27.24 -60.21%
on 12/04/24
-8.18 (-43.01%)
since 04/24/24

Most Recent Stories

More News
Xencor: Q4 Earnings Snapshot

Xencor: Q4 Earnings Snapshot

XNCR : 10.84 (-0.28%)
Xencor: Q3 Earnings Snapshot

Xencor: Q3 Earnings Snapshot

XNCR : 10.84 (-0.28%)
Xencor: Q2 Earnings Snapshot

Xencor: Q2 Earnings Snapshot

XNCR : 10.84 (-0.28%)
Xencor: Q1 Earnings Snapshot

Xencor: Q1 Earnings Snapshot

XNCR : 10.84 (-0.28%)
Xencor: Q4 Earnings Snapshot

Xencor: Q4 Earnings Snapshot

XNCR : 10.84 (-0.28%)
5 Growth Stocks with 66% Upside Potential or More

Here's a closer look at five growth stocks that analysts expect to rally in 2024 as the Fed prepares to pivot to a more dovish policy stance.

SOUN : 9.38 (+7.20%)
RKLB : 21.88 (+7.84%)
XNCR : 10.84 (-0.28%)
GAMB : 12.55 (+2.70%)
GSAT : 19.55 (+2.36%)
2 Growth Stocks With 35% to 150% Upside in 2024

While all eyes are on AI stocks, there are a few undervalued growth stocks that have the potential to provide investors with massive long-term returns.

ACB : 4.71 (+7.05%)
$SPX : 5,484.77 (+2.03%)
CRLBF : 0.7800 (+18.63%)
XNCR : 10.84 (-0.28%)
GTBIF : 6.1900 (+16.57%)
CGC : 1.4900 (+20.16%)
2 Beaten-Down Growth Stocks With 90% or More Upside Potential in 2024

While these stocks have taken a beating this year, Wall Street believes they have major rebound potential in 2024.

TCNNF : 4.6700 (+20.33%)
XNCR : 10.84 (-0.28%)
Xencor: Q3 Earnings Snapshot

Xencor: Q3 Earnings Snapshot

XNCR : 10.84 (-0.28%)
Xencor: Q2 Earnings Snapshot

Xencor: Q2 Earnings Snapshot

XNCR : 10.84 (-0.28%)

Business Summary

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

See More

Key Turning Points

3rd Resistance Point 13.56
2nd Resistance Point 13.00
1st Resistance Point 11.93
Last Price 10.84
1st Support Level 10.30
2nd Support Level 9.74
3rd Support Level 8.67

See More

52-Week High 27.24
Fibonacci 61.8% 19.57
Fibonacci 50% 17.20
Fibonacci 38.2% 14.83
Last Price 10.84
52-Week Low 7.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective